Trial intelligence / Profile preview

Dexmedetomidine versus ketamine for reducing analgesic requirement in opioid-dependent surgical patients

IRCT201307203436N3Phase 3Completed

Sponsor
Anesthesiology Research Center
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in opioid use disorder (OUD) comparing Dexmedetomidine arm with Ketamine arm (2 arms). Primary endpoint: Analgesic requirement. Started Aug 2013; status: completed.

02

Drugs

dexmedetomidineketamine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on IRCT201307203436N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201307203436N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call